Apollo Endosurgery inc achieved in the fourth quarter 2022, above Company average Revenue growth of 31.81% year on year, to $ 21.31 millions.
Looking into fourth quarter 2022 results within Medical Equipment & Supplies industry 88 other companies have achieved higher Revenue growth. While Apollo Endosurgery Inc ' s Revenue rise of 31.81% ranks overall at the positon no. 1974 in the fourth quarter 2022.
APEN Revenue ( Y/Y Growth %)
2022
2021
2020
2019
4th Quarter
December
31.81 %
26.03 %
13.94 %
-20.37 %
3rd Quarter
September
17.82 %
194.5 %
-60.42 %
-9.75 %
2nd Quarter
June
39.32 %
29.29 %
-18.85 %
-16.07 %
1st Quarter
March
29.55 %
7.26 %
-21.01 %
-
FY
29.17 %
44.49 %
-23.6 %
-
Financial Statements
Apollo Endosurgery Inc 's fourth quarter 2022 Revenue
Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022
Apollo Endosurgery Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
127.25 %
5.03 %
-47.34 %
(Sep 30 2020)
APEN's IV. Quarter Q/Q Revenue Comment
Apollo Endosurgery inc achieved in the IV. Quarter 2022 above company average sequential Revenue increase of 8.91%, to $ 21.31 millions, from $19.57 millions in the third quarter. APEN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 86 other companies have achieved higher Revenue quarter on quarter growth. While Apollo Endosurgery Inc 's Revenue growth quarter on quarter, overall rank is 1399.
Apollo Endosurgery inc achieved in the IV. Quarter 2022 above company average sequential Revenue increase of 8.91%, to $ 21.31 millions, from $19.57 millions in the third quarter. APEN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 86 other companies have achieved higher Revenue quarter on quarter growth. While Apollo Endosurgery Inc 's Revenue growth quarter on quarter, overall rank is 1399.
Apollo Endosurgery Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Dec 31 2022)
12 Months Ending (Sep 30 2022)
12 Months Ending (Jun 30 2022)
12 Months Ending (Mar 31 2022)
12 Months Ending (Dec 31 2021)
Cumulative Revenue 12 Months Ending
$ 76.86
$ 71.71
$ 68.75
$ 63.30
$ 59.50
Y / Y Revenue Growth (TTM)
29.17 %
27.71 %
52.15 %
50.54 %
44.49 %
Year on Year Revenue Growth Overall
Ranking
# 562
# 778
# 277
# 191
# 318
Seqeuential Revenue Change (TTM)
7.17 %
4.31 %
8.61 %
6.39 %
5.96 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1924
# 1353
# 896
# 369
# 405
Cumulative Revenue growth Comment
Apollo Endosurgery Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 29.17% year on year, to $ 77 millions if the fiscal year would have ended in Dec 31 2022. Apollo Endosurgery Inc 's trailing twelve months Revenue growth was higher than company's average 13.2% and higher than 27.71% growth in Sep 30 2022. But from twelve months ended Sep 30 2022 rise was beneth at 7.17 % from $71.71 millions achieved in the period from Sep 30 2022 to Dec 31 2021. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at13.2%. The momentum is even more impressive from twelve months ended Sep 30 2022 exhibited at 7.17 % increase from $71.71 millions in the period from Sep 30 2022 to Dec 31 2021.
In the Healthcare sector 109 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 562, from total ranking in previous quarter at 778.
Apollo Endosurgery Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 29.17% year on year, to $ 77 millions if the fiscal year would have ended in Dec 31 2022. Apollo Endosurgery Inc 's trailing twelve months Revenue growth was higher than company's average 13.2% and higher than 27.71% growth in Sep 30 2022. But from twelve months ended Sep 30 2022 rise was beneth at 7.17 % from $71.71 millions achieved in the period from Sep 30 2022 to Dec 31 2021. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at13.2%. The momentum is even more impressive from twelve months ended Sep 30 2022 exhibited at 7.17 % increase from $71.71 millions in the period from Sep 30 2022 to Dec 31 2021.
In the Healthcare sector 109 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 562, from total ranking in previous quarter at 778.
About Apollo Endosurgery Inc Revenue Growth Rates (APEN), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
54.99%